Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLOCK-SAH: PPF Block for Acute Headache in Subarachnoid Hemorrhage
NCT06008795Phase 2Recruiting
- Sponsor
- University of Florida
- Start
- Dec 2023
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ropivacaine, dexamethasone in Headache, sponsored by University of Florida. Started Dec 2023; status: recruiting.
02
Drugs
ropivacainedexamethasone
03
Conditions
Headache
Beyond the preview
Go deeper on NCT06008795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06008795.